age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
52.961
|
male
| 1
| 7
|
Lung Cancer
|
Cancer
| 1
| null | null | 41
| 8,388
| 5,345.3594
| null | 12
|
black
| 29.699219
| 15
| 0.212982
| 0.021999
| 1
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr before sadm
| -1
| 83
| 32.195313
| 112
| 16
| 37.39844
| null | 2.799805
| 1.099854
| 0.699951
| 142
| null | null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
62.25098
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 5,801
| 3,634.0312
| null | 7
|
white
| 18.296875
| 17
| 0.891968
| 0.81897
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 110
| 17.296875
| 100
| 20
| 36.69531
| 176.65625
| 3.899902
| 0.399963
| 1.199951
| 143
| 7.30957
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,779
| 0
|
63.54797
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 35,637
| 15,254.7578
| null | 20.666656
|
white
| 20.699219
| 34
| 0.863892
| 0.773926
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 18
| 147
| 8.199219
| 115
| 6
| 37.79688
| 140
| 4.199219
| 1.5
| 1.399902
| 148
| 7.299805
| null | null | null | null | 1
| null | 1
| 1,778
| 0
|
71.30695
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 35,785
| 29,547.8125
| null | 27
|
white
| 30.699219
| 49
| 0.600952
| 0.493958
| 5
| 1
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 4
| 68
| 10.199219
| 103
| 32
| 38.39844
| 61
| null | null | 1.599854
| 134
| 7.489258
| null | null | null | null | 5
|
SIP>=30
| 5
| 1,777
| 0
|
70.15497
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 4,469
| 2,853.1348
| null | 9
|
white
| 18.597656
| 10
| 0.661987
| 0.360962
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 4
| 80
| 20.296875
| 90
| 20
| 37.79688
| null | 3.299805
| 0.5
| 0.699951
| 137
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 51
| 1
|
61.98798
|
male
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 20,414
| 7,250.3516
| null | 30
|
white
| 34.898438
| 56
| 0.422974
| 0.303955
| 1
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 7
| 52
| 5.5
| 110
| 12
| 38.89844
| 145
| 1.699951
| 1.699951
| 1.899902
| 131
| 7.30957
| null | null | null | null | 0
|
SIP>=30
| 0
| 225
| 1
|
75.737
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 11,378
| 6,638.8867
| null | 16
|
white
| 17.199219
| 18
| 0.860962
| 0.769897
| 1
| 0
| 0
|
no
| 0.99
| 0.97
|
no dnr
| 7
| 77
| 13.099609
| 100
| 20
| 37.19531
| 295.1875
| null | null | 0.899902
| 139
| 7.439453
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,215
| 1
|
57.09198
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
| null | 0
| 40,735
| 20,608.4844
| null | 26.666656
|
white
| 18.898438
| 28
| 0.885986
| 0.845947
| 1
| 1
| 0
|
no
| 0.9
| 0.95
|
no dnr
| 15
| 58
| 6.699219
| 110
| 24
| 38.59375
| 280
| null | null | 0.899902
| 136
| 7.489258
| null | null | null | 5
| 0
|
no(M2 and SIP pres)
| 0
| 1,775
| 0
|
83.55896
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
under $11k
| 0
| 9,225
| 6,452.3867
| null | 11
|
white
| 26.898438
| 46
| 0.615967
| 0.429993
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 7
| 107
| 16.796875
| 60
| 25
| 36.69531
| 117.5
| null | null | 1.5
| 144
| 7.279297
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 928
| 1
|
53.54999
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 47,802
| 29,025.8438
| null | 19.666656
|
white
| 21.796875
| 29
| 0.875
| 0.792969
| 1
| 1
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 22
| 77
| 7.5
| 63
| 24
| 36.69531
| 170
| null | null | 1.899902
| 144
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 904
| 1
|
66.58698
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 13
|
>$50k
| 0
| 7,248
| 4,762.5352
| null | 12
|
white
| 22.296875
| 18
| 0.584961
| 0.264954
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.65
|
no dnr
| 6
| 100
| 3
| 100
| 20
| 35.59375
| null | 3.099609
| 0.199982
| 1.099854
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 359
| 1
|
89.16095
|
male
| 1
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 9
| 74,657
| 46,843.25
| null | 14.75
|
white
| 28.5
| 55
| 0.571899
| 0.461975
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
dnr after sadm
| 57
| 47
| 9.099609
| 72
| 26
| 38.39844
| 203.3125
| null | null | 2.5
| 138
| 7.269531
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 62
| 1
|
85.45697
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 31,884
| 20,765.8125
| null | 32.5
|
white
| 30.796875
| 50
| 0.40094
| 0.280945
| 8
| 0
| 1
|
yes
| 0.8
| 0.65
|
dnr after sadm
| 10
| 46
| 10.199219
| 105
| 28
| 36.29688
| 346.625
| 2.299805
| 1.299805
| 1.5
| 138
| 7.269531
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 12
| 1
|
66.53296
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 14,115
| 6,797.5898
| null | 18
|
white
| 17.296875
| 33
| 0.879883
| 0.836914
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 55
| 7
| 68
| 24
| 38.79688
| 252.5
| 2.899902
| 0.299988
| 1.5
| 141
| 7.389648
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,771
| 0
|
64.34998
|
female
| 1
| 6
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 4,814
| 3,547.2793
| null | 12
|
white
| 40.796875
| 25
| 0.25
| 0.031998
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 1
| 93
| 11.798828
| 100
| 20
| 36.09375
| null | 1.899902
| 4.399414
| 0.899902
| 146
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.105469
| 6
| 1
|
91.23895
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
| null | 0
| 49,254
| 17,402.25
| null | 38.333313
|
white
| 25.199219
| 41
| 0.606934
| 0.500977
| 1
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 16
| 47
| 8.798828
| 47
| 8
| 36.89844
| 230
| null | 0.5
| 1.299805
| 137
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.51416
| 18
| 1
|
52.43799
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 3,754
| 2,510.0801
| null | 7
|
white
| 9.5
| 15
| 0.846924
| 0.662964
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 4
| 90
| 10.5
| 90
| 20
| 37.79688
| 342.8125
| 4.099609
| 2.099609
| 1.299805
| 136
| 7.489258
| null | null | null | null | null | null | 2.921875
| 63
| 1
|
69.68695
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| 7,594
| 4,807.0508
| null | 13
|
white
| 14.798828
| 15
| 0.73999
| 0.473999
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 97
| 4.099609
| 100
| 20
| 38.19531
| 280.9375
| null | null | 1
| 144
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,768
| 0
|
68.01099
|
female
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 13
|
$25-$50k
| 0
| 65,515
| 35,741.6875
| null | 21.25
|
white
| 24.796875
| 30
| 0.750977
| 0.671997
| 4
| 0
| 1
|
no
| 0.5
| 0.5
|
no dnr
| 40
| 53
| 11.199219
| 70
| 8
| 38.59375
| 182
| null | null | 1.099854
| 157
| 7.429688
| null | null | null | null | 0
| null | 0
| 1,608
| 1
|
78.00995
|
male
| 1
| 26
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 9
| 55,591
| 25,233.4688
| null | 15.5
|
white
| 23.597656
| 40
| 0.705933
| 0.544922
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 20
| 117
| 16.898438
| 70
| 20
| 35.59375
| 169.5625
| 3.599609
| 0.399963
| 1.699951
| 146
| 7.319336
| null | null | null | null | null |
<2 mo. follow-up
| 2.724609
| 26
| 1
|
66.57599
|
male
| 0
| 32
|
Lung Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 28,609
| 21,191.9844
| null | 9.75
|
hispanic
| 16.398438
| 11
| 0.715942
| 0.435974
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 87
| 13.398438
| 60
| 20
| 37
| null | 3.599609
| 0.599976
| 0.899902
| 133
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.816406
| 58
| 1
|
71.55096
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 13
| null | 0
| 4,155
| 2,700.1113
| null | 6
|
white
| 24.398438
| 33
| 0.511963
| 0.189972
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 60
| 12.599609
| 110
| 25
| 36.79688
| 323.75
| 3.099609
| 0.399963
| 1
| 143
| 7.419922
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 42
| 1
|
93.63196
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 20,328
| 6,779.9258
| null | 34
|
white
| 29.097656
| 51
| 0.487
| 0.368958
| 1
| 0
| 1
|
yes
| 0.5
| 0.1
|
dnr after sadm
| 6
| 55
| 12.099609
| 62
| 36
| 36.79688
| 177.5
| null | 0.799927
| 2.199707
| 139
| 7.379883
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 8
| 1
|
55.51498
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 3
| 8
|
$11-$25k
| 0
| 4,136
| 2,525.0195
| null | 6
|
white
| 16.898438
| 9
| 0.731934
| 0.461975
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 3
| 100
| 11.699219
| 92
| 20
| 36.69531
| null | null | null | 0.799927
| 137
| null | null | null | null | 0
| 1
|
SIP>=30
| 1
| 410
| 1
|
84.80499
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 9
| 13,374
| 9,147.9844
| null | 10
|
white
| 23.699219
| 40
| 0.700928
| 0.537964
| 1
| 1
| 1
|
no
| 0.9
| 0.5
|
dnr after sadm
| 10
| 107
| 6
| 80
| 20
| 35.59375
| 276
| 3
| 0.5
| 2.399902
| 136
| 7.5
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 35
| 1
|
46.08398
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 9,901
| 7,630.4258
| null | 3
|
black
| 13.798828
| 6
| 0.800903
| 0.575928
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 93
| 12.699219
| 76
| 16
| 36.69531
| null | 3.599609
| 0.399963
| 1
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,761
| 0
|
53.99597
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 14,066
| 7,690.0742
| null | 19
|
black
| 23.5
| 21
| 0.846924
| 0.794922
| 1
| 0
| 0
|
no
| 1
| 0.95
|
no dnr
| 11
| 64
| 11.699219
| 110
| 25
| 38.09375
| 179.5625
| null | null | 0.799927
| 136
| 7.449219
| null | null | null | null | null | null | 2.565918
| 1,759
| 0
|
44.89499
|
female
| 0
| 63
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 0
| 176,328
| 64,412.5625
| null | 50.75
|
white
| 42.398438
| 70
| 0.522949
| 0.407959
| 1
| 0
| 0
|
no
| 0.15
| 0.003375
|
no dnr
| 63
| 53
| 41.195313
| 130
| 22
| 36.39844
| 50
| 1.899902
| 1.199951
| 1.5
| 129
| 7.279297
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,757
| 0
|
67.75098
|
male
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 46,516
| 22,635.3438
| null | 43
|
white
| 25.898438
| 63
| 0.566895
| 0.454956
| 10
| 0
| 0
|
yes
| 0.75
| 0.5
|
dnr after sadm
| 8
| 57
| 12.199219
| 145
| 14
| 36.89844
| 211.65625
| null | 0.5
| 11.798828
| 138
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 10
| 1
|
75.159
|
female
| 1
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 24,431
| 10,405.8281
| null | 39
|
white
| 45.695313
| 58
| 0.138977
| 0.031998
| 4
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 6
| 43
| 29.398438
| 127
| 24
| 34.59375
| 195
| 2.799805
| null | 1.199951
| 132
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
69.59094
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 5,894
| 3,981.5547
| null | 15
|
white
| 24.199219
| 48
| 0.792969
| 0.666992
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 6
| 63
| 11
| 80
| 25
| 35.59375
| 224
| null | 1.599854
| 2.199707
| 135
| 7.489258
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 816
| 1
|
31.76999
|
male
| 0
| 23
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 33,867
| 22,225.9375
| null | 18.666656
|
white
| 24
| 20
| 0.642944
| 0.333984
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.25
|
no dnr
| 23
| 72
| 16.796875
| 124
| 20
| 39.39844
| null | null | null | 0.599976
| 133
| null | null | null | null | 5
| 2
|
adl>=4 (>=5 if sur)
| 2
| 72
| 1
|
74.83398
|
female
| 1
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 10,763
| 6,619.1445
| null | 15
|
white
| 26
| 47
| 0.738892
| 0.590942
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 70
| 11.898438
| 100
| 50
| 36.09375
| 263.3125
| 2.199707
| 0.399963
| 0.799927
| 142
| 7.429688
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 7
| 1
|
74.66699
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 46,033
| 19,954.7188
| null | 30
|
white
| 36.398438
| 67
| 0.492981
| 0.375977
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 25
| 52
| 13
| 113
| 32
| 37.59375
| 120
| 2.099609
| 0.399963
| 2
| 150
| 7.479492
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,323
| 1
|
69.68097
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 6,840
| 4,699.6172
| null | 14
|
white
| 16.097656
| 17
| 0.714966
| 0.434998
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 6
| 77
| null | 74
| 20
| 36.79688
| null | 3.199707
| 0.299988
| 1
| 139
| null | null | null | null | null | 0
| null | 0
| 1,753
| 0
|
75.66895
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 20,399
| 17,433.4219
| null | 18.5
|
white
| 21.699219
| 27
| 0.765991
| 0.690918
| 5
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 8
| 108
| 5.599609
| 78
| 24
| 36.59375
| 173.3125
| 2.699707
| null | 1.799805
| 140
| 7.389648
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 64
| 1
|
70.09698
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 6,388
| 3,125.3809
| null | 9
|
white
| 17.5
| 16
| 0.86792
| 0.780884
| 1
| 0
| 0
|
no
| 0.97
| 0.97
|
no dnr
| 4
| 60
| 10.099609
| 60
| 20
| 36.09375
| 361.875
| null | null | 1.099854
| 144
| 7.319336
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,750
| 0
|
79.05499
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 9,388
| 6,350.4453
| null | 11
|
white
| 23.398438
| 43
| 0.603882
| 0.414978
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr before sadm
| -1
| 97
| 0.599976
| 76
| 32
| 36.09375
| 190
| 3.099609
| 0.699951
| 0.599976
| 147
| 7.389648
| null | null | null | 5
| 5
|
adl>=4 (>=5 if sur)
| 5
| 68
| 1
|
69.06195
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 12,943
| 5,987.9141
| null | 12.5
|
white
| 20
| 33
| 0.845947
| 0.792969
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 9
| 69
| 9.398438
| 72
| 24
| 37.89844
| 348
| 3.099609
| 1.099854
| 4.099609
| 143
| 7.30957
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,749
| 0
|
83.29596
|
female
| 0
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 13
| null | 0
| 47,413
| 27,751.4062
| null | 16.333328
|
white
| 24
| 38
| 0.734985
| 0.584961
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 23
| 47
| 5.299805
| 121
| 24
| 37.79688
| null | 3.899902
| 0.299988
| 1.299805
| 146
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,748
| 0
|
61.30298
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
| null | 0
| 37,775
| 27,634.4375
| null | 21.666656
|
other
| 19.597656
| 26
| 0.869995
| 0.824951
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 68
| 10
| 65
| 32
| 39.09375
| 177.5
| 3.099609
| 0.799927
| 1.299805
| 141
| 7.379883
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,748
| 0
|
90.073
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 9,664
| 7,518.3672
| null | 9
|
white
| 22.199219
| 27
| 0.681885
| 0.588989
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
dnr before sadm
| -1
| 120
| 4.799805
| 59
| 16
| 36.19531
| 425
| 3.599609
| 0.199982
| 1.5
| 132
| 7.369141
| null | null | null | 4
| 2
|
no(M2 and SIP pres)
| 2
| 240
| 1
|
72.59698
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 17
|
$11-$25k
| 0
| 65,724
| 42,684
| null | 50
|
white
| 45.09375
| 61
| 0.156982
| 0.076996
| 11
| 0
| 0
|
no
| 0.4
| 0.2
|
no dnr
| 3
| 50
| 28.097656
| 120
| 12
| 36.69531
| 100
| 2.599609
| null | 3.5
| 129
| 7.30957
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
89.28094
|
male
| 0
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 8
| null | 0
| 15,407
| 7,858.9844
| null | 16.5
|
white
| 37.5
| 68
| 0.292969
| 0.181976
| 1
| 1
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 2
| 50
| 45
| 116
| 28
| 36.09375
| 199.96875
| 3
| null | 5.799805
| 140
| 7.299805
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 215
| 1
|
78.39795
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 7,293
| 5,625.7344
| null | 13
|
hispanic
| 16.898438
| 23
| 0.835938
| 0.731934
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 117
| 8.798828
| 65
| 24
| 37.19531
| 283.3125
| null | null | 1.799805
| 138
| 7.429688
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,112
| 1
|
63.44098
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 13,301
| 7,643.9961
| null | 36
|
white
| 28.5
| 49
| 0.741943
| 0.660889
| 1
| 1
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 7
| 53
| 14.199219
| 100
| 24
| 37.69531
| 355
| 3.599609
| 0.799927
| 4.399414
| 136
| 7.429688
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 347
| 1
|
70.90997
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 9
|
under $11k
| 0
| 14,078
| 10,750.4922
| null | 34
|
white
| 20.796875
| 37
| 0.81897
| 0.757935
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 7
| 57
| 9.5
| 112
| 26
| 38.59375
| 224.46875
| null | null | 1
| 136
| 7.519531
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,069
| 1
|
48.48499
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 9,580
| 5,006.9414
| null | 14
|
white
| 29.597656
| 26
| 0.782959
| 0.711914
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 8
| 63
| 6
| 58
| 26
| 35.59375
| 428.5625
| 3
| 3
| 0.5
| 128
| 7.459961
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,738
| 0
|
75.75897
|
male
| 0
| 67
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
$11-$25k
| 0
| 101,328
| 73,976.6875
| null | 31.75
|
black
| 30.398438
| 54
| 0.582886
| 0.472961
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 67
| 153
| 12.298828
| 130
| 8
| 37.79688
| 145
| null | null | 2.199707
| 134
| 7.40918
| null | null | null | 2
| 0
|
SIP>=30
| 0
| 1,737
| 0
|
84.57495
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 19,696
| 12,471.5234
| null | 19.666656
|
white
| 20.5
| 38
| 0.787964
| 0.659912
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 9
| 107
| 8.199219
| 64
| 32
| 36.09375
| null | 3.799805
| 1.5
| 2.099609
| 145
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.382324
| 16
| 1
|
88.50696
|
male
| 1
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 9
| 8,194
| 5,980.1562
| null | 8.5
|
white
| 18
| 31
| 0.784912
| 0.654907
| 1
| 0
| 1
|
no
| 0.9
| 0.8
|
dnr after sadm
| 1
| 83
| 7.899414
| 80
| 25
| 37.79688
| 390.4375
| 3.899902
| 1.699951
| 2.299805
| 133
| 7.459961
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 10
| 1
|
71.82495
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 44
| 52,016
| 39,866.4688
| null | 24.5
|
white
| 25.796875
| 40
| 0.467957
| 0.348999
| 26
| 1
| 0
|
no
| null | null |
dnr after sadm
| 1
| 77
| 11.699219
| 70
| 32
| 39.39844
| 119
| 2.399902
| 0.299988
| 1.799805
| 138
| 7.30957
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 10
| 1
|
61.19098
|
male
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 12
|
under $11k
| 0
| 27,367
| 12,431.9375
| null | 21
|
white
| 16.097656
| 22
| 0.910889
| 0.850952
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 15
| 100
| 16
| 80
| 25
| 36.09375
| 273.3125
| 4
| 0.799927
| 1.399902
| 136
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.993164
| 402
| 1
|
89.04297
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 58,008
| 38,696.375
| null | 36
|
hispanic
| 25.199219
| 50
| 0.5979
| 0.48999
| 14
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 6
| 59
| 12.5
| 120
| 33
| 38.59375
| 168
| null | 0.399963
| 1
| 146
| 7.389648
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 10
| 1
|
58.50198
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 18,372
| 13,234.2969
| null | 22.5
|
white
| 19.398438
| 30
| 0.806885
| 0.688965
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 12
| 77
| 3.199707
| 70
| 20
| 39.59375
| 242.84375
| 2.799805
| 4.299805
| 0.599976
| 136
| 7.509766
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.262207
| 1,735
| 0
|
81.02698
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
>$50k
| 0
| 11,976
| 8,376.7734
| null | 10.5
|
white
| 19.5
| 46
| 0.783936
| 0.654907
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 10
| 53
| 5.699219
| 80
| 20
| 36.09375
| 266.625
| null | null | 0.899902
| 141
| 7.479492
| null | null | null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 1,733
| 0
|
76.10699
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
$25-$50k
| 0
| 27,917
| 21,123.0625
| null | 32.333313
|
white
| 17.199219
| 23
| 0.843994
| 0.743896
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 107
| 13.699219
| 78
| 8
| 37.69531
| 237.5
| 3.199707
| 0.299988
| 1.599854
| 138
| 7.339844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,733
| 0
|
71.91498
|
female
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 18
|
$11-$25k
| 0
| 21,983
| 14,240.3828
| null | 13
|
white
| 16.296875
| 36
| 0.80188
| 0.679932
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 17
| 103
| 1.799805
| 80
| 25
| 36.09375
| 252.375
| null | null | 1.099854
| 142
| 7.479492
| null | null | null | 1
| 1
|
adl>=4 (>=5 if sur)
| 1
| 78
| 1
|
75.41394
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 45,105
| 22,974.0938
| null | 34.5
|
white
| 22.097656
| 29
| 0.610962
| 0.504883
| 12
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
dnr after sadm
| 7
| 63
| 15
| 112
| 22
| 38.79688
| 185
| null | null | 1.299805
| 141
| 7.389648
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 12
| 1
|
90.08398
|
female
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 12
| null | 0
| 18,263
| 11,832.4766
| null | 11.333328
|
white
| 21
| 25
| 0.687988
| 0.520996
| 1
| 0
| 0
|
no
| 0.6
| 0.15
|
no dnr
| 15
| 97
| 3.799805
| 70
| 20
| 37
| 162.84375
| null | null | 1.599854
| 150
| 7.379883
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 323
| 1
|
78.96796
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 0
|
$11-$25k
| 0
| 16,741
| 12,578.8281
| null | 16
|
white
| 25.097656
| 44
| 0.735962
| 0.653931
| 1
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 13
| 58
| 7.699219
| 65
| 24
| 35.59375
| 136.71875
| null | 0.699951
| 1.399902
| 133
| 7.519531
| null | null | null | 5
| 7
|
no(M2 and SIP pres)
| 7
| 1,732
| 0
|
69.66199
|
female
| 0
| 22
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 41,995
| 27,412.6562
| null | 8.666664
|
white
| 18.5
| 37
| 0.665894
| 0.36499
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 22
| 117
| 9.298828
| 80
| 25
| 36.5
| 340
| 3.199707
| 0.399963
| 1.099854
| 136
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 3.062988
| 43
| 1
|
47.866
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
>$50k
| 0
| 9,214
| 5,951.7148
| null | 11
|
white
| 12.798828
| 19
| 0.944946
| 0.905884
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 8
| 70
| 5.099609
| 80
| 16
| 36.69531
| null | 4
| 0.899902
| 1.599854
| 144
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,731
| 0
|
70.20099
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| 9,812
| 4,801.6211
| null | 19
|
white
| 21.898438
| 28
| 0.81897
| 0.757935
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 77
| 19.097656
| 68
| 30
| 38.89844
| 159.15625
| null | null | 1.299805
| 136
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,729
| 0
|
64.30396
|
male
| 0
| 16
|
Coma
|
Coma
| 1
| 16
|
>$50k
| 41
| 15,716
| 12,380.3438
| null | 10
|
white
| 17.296875
| 31
| 0.613892
| 0.549927
| 1
| 0
| 0
|
yes
| 0.8
| 0.9
|
no dnr
| 16
| 77
| 8.898438
| 62
| 28
| 37.79688
| 352
| 4.199219
| 1.5
| 1.299805
| 134
| 7.539062
| null | null | null | null | null | null | 2.257813
| 1,728
| 0
|
78.95099
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
under $11k
| 0
| 19,168
| 14,840.7812
| null | 19.5
|
black
| 22.898438
| 36
| 0.741943
| 0.593994
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 13
| 117
| 7.449219
| 150
| 26
| 36.09375
| 448
| null | null | 1.099854
| 134
| 7.399414
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,728
| 0
|
62.56
|
male
| 0
| 32
|
Coma
|
Coma
| 1
| 18
|
>$50k
| 44
| 44,236
| 25,587.5156
| null | 22.25
|
black
| 30.398438
| 47
| 0.302979
| 0.231995
| 2
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 7
| 135
| 14.5
| 140
| 28
| 38.29688
| 126.51562
| 3.299805
| null | 1.799805
| 146
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,728
| 0
|
73.25397
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 54,799
| 29,236.5469
| null | 30.666656
|
white
| 29.796875
| 38
| 0.647949
| 0.547974
| 2
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 16
| 49
| 12.599609
| 76
| 24
| 38.39844
| 123.32812
| null | null | 1.299805
| 132
| 7.489258
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,727
| 0
|
71.32898
|
female
| 1
| 15
|
Coma
|
Coma
| 3
| null | null | 94
| 75,051
| 64,077.8125
| null | 34.333313
|
white
| 20.597656
| 46
| 0.165985
| 0.110992
| 13
| 1
| 0
|
no
| 0.75
| 0.25
|
dnr after sadm
| 14
| 67
| 16.597656
| 110
| 32
| 38.79688
| 346
| 2.399902
| null | 1
| 148
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 2.871582
| 15
| 1
|
55.431
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 19,018
| 6,998.5195
| null | 26
|
white
| 33.5
| 42
| 0.613892
| 0.508911
| 1
| 0
| 0
|
yes
| 0.8
| 0.8
|
dnr after sadm
| 6
| 130
| 1.399902
| 140
| 12
| 38.29688
| 121.42188
| 2.599609
| 1.5
| 0.699951
| 140
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.742188
| 7
| 1
|
47.26898
|
male
| 0
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 4,884
| 2,802.9844
| null | 20
|
white
| 19.898438
| 29
| 0.852905
| 0.757935
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 80
| 12.298828
| 80
| 30
| 36.69531
| 456
| 2.799805
| 2.599609
| 0.699951
| 134
| 7.349609
| null | null | null | 1
| null | null | 1.1669
| 1,723
| 0
|
64.77795
|
male
| 0
| 19
|
Lung Cancer
|
Cancer
| 1
| 10
| null | 0
| 25,747
| 15,204.4766
| null | 15
|
white
| 37.296875
| 29
| 0.166992
| 0.011999
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 3
| 81
| 14.599609
| 110
| 32
| 34.79688
| 267.3125
| 2.599609
| 0.699951
| 0.599976
| 135
| 7.439453
| null | null | null | 7
| 5
|
adl>=4 (>=5 if sur)
| 5
| 129
| 1
|
75.72894
|
male
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 168,004
| 99,285.125
| null | 28.75
|
white
| 24.597656
| 47
| 0.464966
| 0.345947
| 55
| 0
| 0
|
no
| 0.5
| 0.1
|
no dnr
| 34
| 70
| 6.5
| 80
| 38
| 36.59375
| 157
| 2.399902
| null | 1.699951
| 150
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 2.651367
| 34
| 1
|
83.61896
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
under $11k
| 0
| 23,847
| 18,103.2031
| null | 10.666664
|
white
| 21
| 38
| 0.769897
| 0.695923
| 2
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 9
| 65
| 10.199219
| 65
| 26
| 35.79688
| 240
| 3
| 0.599976
| 1.699951
| 138
| 7.5
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 51
| 1
|
83.59796
|
male
| 1
| 6
|
Coma
|
Coma
| 2
| null | null | 55
| 8,071
| 5,081.8008
| null | 17
|
white
| 17.296875
| 20
| 0.44397
| 0.369995
| 1
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr before sadm
| -1
| 93
| 12.398438
| 100
| 20
| 38.29688
| 488.3125
| 3.699707
| 0.599976
| 1.5
| 144
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.57959
| 6
| 1
|
82.46399
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 9
| 7,544
| 5,190.9688
| null | 6
|
white
| 22.699219
| 34
| 0.67395
| 0.501953
| 1
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 4
| 73
| 6.799805
| 70
| 20
| 35.59375
| 508
| 3.199707
| 0.599976
| 2.399902
| 141
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 3.986816
| 51
| 1
|
73.62097
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 5,234
| 3,463.6504
| null | 10
|
white
| 33.695313
| 26
| 0.422974
| 0.118988
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 40
| 12.798828
| 80
| 20
| 38.79688
| null | 2.899902
| 1.199951
| 1
| 137
| null | null | null | null | 0
| 5
| null | 5
| 80
| 1
|
47.35098
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$25-$50k
| 0
| 7,408
| 3,852.2246
| null | 34
|
white
| 26.398438
| 37
| 0.843994
| 0.743896
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 68
| 12.199219
| 78
| 28
| 36.29688
| 187.75
| null | null | 3.5
| 136
| 7.40918
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 374
| 1
|
79.06598
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 9
| 46,932
| 35,811.0312
| null | 45
|
white
| 34.59375
| 54
| 0.262939
| 0.156982
| 16
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr before sadm
| 0
| 63
| 17
| 100
| 7
| 35.59375
| 266.625
| 3.599609
| 2.899902
| 2.599609
| 127
| 7.269531
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 10
| 1
|
77.21594
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 46,000
| 23,963.8438
| null | 21.5
|
white
| 29.898438
| 35
| 0.605957
| 0.5
| 3
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 1
| 44
| 9.398438
| 107
| 8
| 36.19531
| 214
| null | null | 1.199951
| 136
| 7.339844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 913
| 1
|
46.06198
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 19
|
>$50k
| 0
| 10,061
| 5,333.6562
| null | 13
|
white
| 19.398438
| 27
| 0.862915
| 0.772949
| 1
| 0
| 0
|
no
| 0.5
| 0.6
|
no dnr
| 8
| 69
| 5.299805
| 112
| 22
| 37.89844
| null | 3.899902
| 3.099609
| 0.799927
| 140
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,719
| 0
|
75.92297
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 8,348
| 5,407.6719
| null | 11
|
white
| 14.898438
| 32
| 0.869995
| 0.783936
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 7
| 77
| 8
| 80
| 25
| 36.69531
| 271.375
| null | null | 1
| 139
| 7.379883
| null | null | null | 6
| 2
|
no(M2 and SIP pres)
| 2
| 1,718
| 0
|
77.93298
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
| null | 0
| 18,693
| 9,089.9141
| null | 23
| null | 23.296875
| 46
| 0.771973
| 0.697998
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 13
| 57
| 9.5
| 69
| 20
| 36.79688
| 206.09375
| 2.299805
| 0.699951
| 5.399414
| 138
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,717
| 0
|
81.07898
|
female
| 0
| 31
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 55,945
| 26,017.2031
| null | 28.5
|
white
| 26.5
| 46
| 0.649902
| 0.471985
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 31
| 53
| 12.398438
| 64
| 42
| 36.89844
| 150
| 3.699707
| 0.799927
| 1.099854
| 145
| 7.30957
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 42
| 1
|
28.25699
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 22,529
| 11,484.4844
| null | 22
|
white
| 22.296875
| 24
| 0.891968
| 0.852905
| 6
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 138
| 12.798828
| 102
| 28
| 38.19531
| 166.65625
| 3
| 1.299805
| 0.899902
| 138
| 7.479492
| null | null | null | 1
| null | null | 1.1669
| 1,714
| 0
|
77.30597
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 11,137
| 8,727.0391
| null | 12
|
white
| 25.5
| 33
| 0.735962
| 0.652954
| 1
| 0
| 1
|
no
| 0.9
| 0.75
|
no dnr
| 10
| 100
| 5
| 59
| 22
| 35.59375
| null | 3
| 0.399963
| 2.599609
| 142
| null | null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,037
| 1
|
83.51294
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 4,691
| 3,171.3438
| null | 7
|
white
| 19.398438
| 37
| 0.807983
| 0.689941
| 1
| 1
| 1
|
no
| 0.8
| 0.7
|
dnr after sadm
| 3
| 93
| 8.298828
| 70
| 25
| 36.09375
| 396
| 3.699707
| 0.899902
| 2.099609
| 142
| 7.299805
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 69
| 1
|
68.24097
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 15
|
under $11k
| 0
| 5,608
| 3,866.9336
| null | 14
|
white
| 16.5
| 35
| 0.886963
| 0.810913
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 73
| 3.799805
| 60
| 20
| 37.19531
| 347.5625
| null | 2.399902
| 1.199951
| 136
| 7.489258
| null | null | null | 2
| 3
| null | 3
| 64
| 1
|
78.245
|
female
| 1
| 42
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 69,147
| 33,901.3438
| null | 22.75
|
white
| 25.597656
| 28
| 0.695923
| 0.530884
| 1
| 0
| 0
|
no
| 0.95
| 0.75
|
dnr after sadm
| 17
| 53
| 17.296875
| 107
| 8
| 35.59375
| 320
| null | 0.5
| 1.099854
| 143
| 7.369141
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 42
| 1
|
60.77197
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
| null | 0
| 8,159
| 4,635.6094
| null | 12
|
white
| 11.5
| 25
| 0.928955
| 0.878906
| 2
| 1
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 7
| 111
| 7.199219
| 64
| 20
| 36.39844
| 336.625
| 4.599609
| 1.099854
| 1.799805
| 141
| 7.549805
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 248
| 1
|
67.96997
|
male
| 0
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| 27,302
| 15,819
| null | 16.5
|
black
| 22.699219
| 34
| 0.608887
| 0.50293
| 4
| 1
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 11
| 145
| 17.398438
| 70
| 24
| 38.19531
| 193.875
| 2.899902
| null | 5.5
| 138
| 7.40918
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,134
| 1
|
75.38098
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
>$50k
| 0
| 25,486
| 14,188.5703
| null | 15.333328
|
white
| 16.699219
| 21
| 0.85498
| 0.804932
| 2
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 17
| 115
| 6.5
| 59
| 24
| 37.89844
| 486
| 2.5
| 0.5
| 1.699951
| 141
| 7.509766
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,708
| 0
|
61.56299
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 9
| 7,588
| 3,814.6152
| null | 4
|
white
| 14.199219
| 16
| 0.901978
| 0.866943
| 1
| 1
| 0
|
no
| 1
| 1
|
no dnr
| 4
| 103
| 7.799805
| 70
| 20
| 36.09375
| 447.5625
| 3.099609
| 0.699951
| 1.099854
| 140
| 7.579102
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,708
| 0
|
69.23199
|
female
| 0
| 32
|
Colon Cancer
|
Cancer
| 2
| 12
| null | 0
| 37,893
| 26,417.5156
| null | 14
|
black
| 19
| 35
| 0.779907
| 0.539917
| 1
| 1
| 0
|
metastatic
| 0.75
| 0.5
|
dnr after sadm
| 9
| 100
| 0.799927
| 80
| 15
| 37.79688
| null | 2.699707
| 1.899902
| 0.699951
| 140
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 1,707
| 0
|
89.32794
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 86,069
| 34,868
| null | 50
| null | 37.796875
| 61
| 0.348999
| 0.231995
| 1
| 0
| 0
|
no
| 0.3
| 0.28
|
dnr after sadm
| 16
| 53
| 4.099609
| 230
| 12
| 39.69531
| 142
| 2.099609
| 5.399414
| 1
| 146
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 3.07959
| 19
| 1
|
84.35297
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 19,014
| 11,332.1406
| null | 9.666664
|
white
| 19.699219
| 24
| 0.802979
| 0.737915
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 16
| 65
| 14.398438
| 68
| 26
| 38.09375
| 385.125
| 3
| 0.599976
| 0.5
| 133
| 7.439453
| null | null | null | null | null | null | 3.170898
| 1,705
| 0
|
73.63397
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 10
|
$11-$25k
| 9
| 21,516
| 13,772.5234
| null | 5.5
|
white
| 18.097656
| 31
| 0.74292
| 0.661987
| 9
| 1
| 0
|
yes
| 0.5
| 0.1
|
no dnr
| 11
| 120
| 17.5
| 90
| 35
| 37.69531
| null | 3.199707
| null | 1.099854
| 145
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
87.41699
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 25,572
| 13,947.4531
| null | 12.333328
|
white
| 24.097656
| 38
| 0.581909
| 0.472961
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
dnr after sadm
| 1
| 70
| 13.398438
| 59
| 28
| 36.09375
| 404
| 2.399902
| 0.799927
| 1.5
| 130
| 7.459961
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,703
| 0
|
75.34296
|
female
| 0
| 89
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 9
| 81,770
| 57,706.5312
| null | 8.75
|
white
| 21
| 27
| 0.772949
| 0.638916
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 16
| 58
| 5.5
| 98
| 24
| 36.69531
| 196.40625
| 3.899902
| 0.799927
| 0.599976
| 130
| 7.389648
| null | null | null | null | null | null | 3.299805
| 1,701
| 0
|
78.53497
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 41
| 10,645
| 7,270.207
| null | 11
|
white
| 19.296875
| 15
| 0.672974
| 0.500977
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr before sadm
| -1
| 77
| 10
| 70
| 20
| 36.59375
| 195
| null | null | 0.5
| 137
| 7.179688
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 14
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.